Anila Lingamneni, EVP, Chief Technology Officer at HAEMONETICS CORP (HAE), sold 2,305 shares at $90.00 ($207K) on 2023-09-11, disclosed to the SEC on 2023-09-13.
Scheduled sale ($207k) by EVP, Chief Technology Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HAE | SELL | 2023-06-01 | $384K | — | Filing → |
| HAE | SELL | 2022-05-23 | $164K | — | Filing → |
| HAE | SELL | 2022-04-19 | $11K | — | Filing → |